Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms

This publication has 27 references indexed in Scilit:

• Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas
  Journal of Clinical Oncology, 2005
• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
  Nature Immunology, 2003
• Identification of a Kb-restricted CTL Epitope of β-Galactosidase: Potential Use in Development of Immunization Protocols for “Self” Antigens
  Methods, 1997
• Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
  Vaccine, 1996
• Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus
  AIDS Research and Human Retroviruses, 1991
• Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules
  Science, 1990
• Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.
  The Journal of Experimental Medicine, 1989
• Stimulation of Myelopoiesis in Patients with Aplastic Anemia by Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1988
• Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.
  The Journal of Experimental Medicine, 1987
• Growth of factor-dependent hemopoietic precursor cell lines.
  The Journal of Experimental Medicine, 1980